Successful mobilization of peripheral blood stem cells in children with cancer using plerixafor (Mozobil™) and granulocyte-colony stimulating factor

Drug Design, Development and Therapy

Volumn 5, Issue , 2011, Pages 407-409

  Avramova, Boryana E ^a   Yordanova, Maya N ^a   Konstantinov, Dobrin N ^a   Bobev, Dragan G ^a  

^a Specialized Hospital for Treatment of Children with Onco Haematological Diseases   (Bulgaria)

Author keywords

Children; G CSF; Mobilization; Plerixafor; Stem cells

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; HETEROCYCLIC COMPOUND;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CHILD; CHILDHOOD CANCER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKAPHERESIS; LYMPHOCYTE COUNT; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; STEM CELL MOBILIZATION; T LYMPHOCYTE; THERAPY EFFECT; TREATMENT FAILURE; AUTOTRANSPLANTATION; BLOOD CELL COUNT; METABOLISM; METHODOLOGY; NEOPLASM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ANTIGENS, CD34; BLOOD CELL COUNT; CHILD; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; LEUKAPHERESIS; MALE; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84856198748     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S19157     Document Type: Article

References (7)

1. Nimmagadda S, Sweiss K, Mahmud N, Park Y, Rondelli D. Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF. Bone Marrow Transplant. 2010;45(6): 1121-1122.
2. Pusic I, Jiang SY, Landua S, et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant. 2008;14(9): 1045-1056.
3. Hübel K, Fresen MM, Salwender H, et al. Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program. Bone Marrow Transplant. [Epub Oct 25, 2010].
4. Toledano H, Yahel A, Cohen I, Yaniv I, Stein J. Successful mobilization, harvest and transplant of peripheral blood stem cells using AMD3100 and G-CSF following high dose craniospinal irradiation for medulloblastoma in a young child. Pediatr Blood Cancer. 2010;54(4):613-615.
5. Jantunen E, Penttila K, Pyorala M, Mahlamaki E, Kuittinen, Nousiainen T. Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients. Bone Marrow Transplant. 2011;46(2):308-309. [Epub Apr 19, 2010].
6. Cardenoux C, Deméocq F, Kanold J, et al. Pegfilgrastim plus AMD 3100 for stem-cell mobilization in children. Pediatr Blood Cancer. 2010; 55(4):769.
7. Stephen K, Montgomery K, Bateman C, Calandra G, Shaw PJ. Successful mobilization, harvest, and transplant of stem cells following AMD3100 in 3 pediatric patients. The Australian experience. Biol Blood Marrow Transplant. 2006;12:157.